Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Research ArticleContinuing Education

51Cr Red Blood Cells in the Study of Hematologic Disease: A Historical Review

George H. Hinkle
Journal of Nuclear Medicine Technology December 2024, 52 (4) 299-305; DOI: https://doi.org/10.2967/jnmt.124.267702
George H. Hinkle
College of Pharmacy, Ohio State University, Columbus, Ohio
RPh, BCNP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Decay scheme for 51Cr. EC = electron capture.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Composition of blood and components of blood volume. Hematocrit (arrow) is fractional relationship between plasma volume and red cell volume. (Reprinted from (23).)

Tables

  • Figures
    • View popup
    TABLE 1.

    Requirements of Radiolabeled Red Blood Cells for In Vivo Studies

    Requirement no.Description
    1Procedure, chemicals, and radionuclide are nontoxic to cell
    2Labeling is independent of age of cell (nonspecific)
    3Cellular labeling is firm, with no elution
    4Cells are not reutilized
    • View popup
    TABLE 2.

    Radiolabeling of Red Blood Cells with 51Cr Using Citrate Washing Procedure

    StepProcedure
    110 mL of blood are placed in sterile, empty 25-mL vial
    22 mL of acid-citrate-dextrose anticoagulant are added and swirled gently to mix
    35 mL of citrate-phosphate buffer (pH 6.4–6.9) are added and swirled gently to mix
    4Cell suspension is centrifuged gently, and supernatant is removed/discarded
    5Washed cells are resuspended using normal saline solution
    60.925 MBq (25 μCi) of 51Cr sodium chromate is added and swirled gently to mix
    7Incubation is performed at room temperature with occasional mixing for 20 min
    8Cell suspension is centrifuged gently, and supernatant is removed/discarded
    951Cr-labeled cells are resuspended using normal saline solution
    • View popup
    TABLE 3.

    International Committee for Standardization in Haematology 51Cr Radiolabeling of Red Blood Cells

    StepProcedure
    1Whole blood (10 volumes) is added to NIH ACD-A solution (1–5 volumes)
    2Cell suspension is centrifuged gently (∼1,000 g) for 5 min
    3Supernatant is removed and discarded
    451Cr sodium chromate (7.4 kBq/kg of body weight) in volume ≥ 0.2 mL is added and mixed gently
    5Incubation is performed for 15 min at 37°C
    651Cr-labeled cells are washed twice in 4–5 volumes of isotonic saline
    7Cells are resuspended in volume of isotonic saline to provide infusion volume of 10 mL
    • NIH ACD-A = National Institutes of Health acid citrate dextrose A.

    • View popup
    TABLE 4.

    Sodium Chromate 51Cr Injection USP Prescribing Information Radiolabeling Procedure

    StepProcedure
    1Whole blood (30–50 mL) is added to sterile vial containing ACD solution (5–10 mL) with gentle mixing
    21.85–7.4 MBq (50–200 μCi) of 51Cr sodium chromate are added to vial, and whole-blood suspension is incubated at room temperature with frequent gentle mixing (swirling)
    3Red blood cell labeling is terminated with addition of 50–100 mg of ascorbic acid for injection USP
    451Cr whole blood is centrifuged, and supernatant (plasma) radioactivity is removed
    551Cr red blood cells are resuspended in normal saline solution USP to known volume
    6Red blood cells are assayed in dose calibrator and reinjected into patient
    • ACD = acid citrate dextrose.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 52 (4)
Journal of Nuclear Medicine Technology
Vol. 52, Issue 4
December 1, 2024
  • Table of Contents
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
51Cr Red Blood Cells in the Study of Hematologic Disease: A Historical Review
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
51Cr Red Blood Cells in the Study of Hematologic Disease: A Historical Review
George H. Hinkle
Journal of Nuclear Medicine Technology Dec 2024, 52 (4) 299-305; DOI: 10.2967/jnmt.124.267702

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
51Cr Red Blood Cells in the Study of Hematologic Disease: A Historical Review
George H. Hinkle
Journal of Nuclear Medicine Technology Dec 2024, 52 (4) 299-305; DOI: 10.2967/jnmt.124.267702
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • HISTORICAL DEVELOPMENT
    • CHROMIUM AND ITS RADIONUCLIDES
    • 51Cr DECAY
    • 51Cr RED BLOOD CELL LABELING
    • RADIOPHARMACEUTICALS
    • CLINICAL USE
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Assessment of Cardiac Sarcoidosis with PET/CT
  • Illuminating the Hidden: Standardizing Cardiac MIBG Imaging for Sympathetic Dysfunction
  • Recognizing and Responding to the Acute Cardiac Stress Patient
Show more Continuing Education

Similar Articles

Keywords

  • 51Cr red blood cells
  • red blood cell volume/mass
  • red blood cell survival
SNMMI

© 2025 SNMMI

Powered by HighWire